Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-469
Closed -$249K – 1432
2024
Q4
$249K Sell
469
-15
-3% -$8.46K 0.03% 285
2024
Q3
$291K Buy
484
+55
+13% +$31.2K 0.05% 235
2024
Q2
$231K Buy
429
+417
+3,475% +$239K 0.03% 393
2024
Q1
$7.69K Sell
12
-316
-96% -$192K 0.01% 306
2023
Q4
$192K Buy
328
+86
+36% +$48.1K 0.03% 296
2023
Q3
$126K Buy
+242
New +$126K 0.04% 363

Other funds holding CHE

ORG Partners's CHE Position: Q1 2025 in Review

ORG Partners sold out of Chemed (CHE) in Q1 2025, closing a stake of 469 shares — an estimated $249K sold.

ORG Partners first reported a position in CHE in Q3 2023 and held it in 6 quarters. The position peaked at $291K in Q3 2024. 554 funds tracked by Wall St. Rank hold CHE as of Q1 2025.

  • ORG Partners reported no remaining Chemed position as of Q1 2025 after selling out during the quarter.
  • ORG Partners sold 469 Chemed shares in Q1 2025, an estimated $249K.
  • ORG Partners first reported a position in Chemed in Q3 2023 and held it in 6 quarters.
  • ORG Partners's Chemed position peaked at $291K in Q3 2024.
  • 554 funds tracked by Wall St. Rank held Chemed as of Q1 2025.

Based on ORG Partners's 13F filing for Q1 2025, filed 21 Apr 2025.